Traditional Chinese herbal medicine in European Union: State of art, challenges, and future perspectives focusing on Italian market

被引:1
|
作者
Bilia, Anna Rita [1 ]
Ballerini, Rebecca [1 ]
Qu, Liping [2 ]
Wang, Mei [3 ,4 ,5 ]
机构
[1] Dept Chem Ugo Schiff, I-50019 Sesto Fiorentino, Italy
[2] Chengdu Univ Tradit Chinese Med, State Key Lab Southwestern Chinese Med Resources, Chengdu 610037, Peoples R China
[3] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands
[4] Northwest Univ, Xian 710069, Peoples R China
[5] SU BioMed, NL-2333 BD Leiden, Netherlands
关键词
European and Italian market; food supplements; herbal medicinal products medical device; and cosmetic; traditional Chinese medicine; PRODUCTS; MONOGRAPH;
D O I
10.1016/j.chmed.2024.11.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Traditional Chinese herbal medicine (TCM) has been used in China for thousands of years as an integral part of the healthcare system.The use of botanical products deriving from plants from TCM has become very spread and rooted in European Union (EU), generating a manufacturing industry of pronounced size, in particular the segment of food supplements, but recently also medical devices and cosmetics based on plants from TCM, especially in Italy. Only seven Herbal Medicinal Products (HMP) based on plants from TCM are present in EU besides more than 100 monographs on TCM plants are present in the European Pharmacopoeia. Indeed, the number of herbal monographs of European Medicine Agency (EMA) which report the main data on safety and efficacy of medicinal plants from TCM are very limited and this could be a reason for the limited number of HMP based on herbal drugs used in TCM. It is clear that those botanicals based on TCM but not classified as HMP can represent a sort of "borderline" products. Very likely, they are present on the European market because of the simpler authorization when compared with HMP. Some examples of these categories (food supplements and medical devices) containing plants from TCM and marketed in Italy are reported in this review. Consequently, it is urgent the need to clarify their categorization, also fundamental for the consumer protection. It is imperative the establishment of EU quality standards and official registration for Chinese herbal medicinal products, even if they are marketed as food supplements, medicinal devices or cosmetics because the international quality standards International Organization for Standardization Technical Committee 249-Traditional Chinese Medicine (ISO/ TC249) can harmonize the quality control and promote the trading internationally. Governmental organizations together with companies producing TCM should work together to accelerate the legislation of laws pertaining to TCM, and generate an environment where TCM does not just continue to exist but truly develop. (c) 2024 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:3 / 18
页数:16
相关论文
共 14 条
  • [1] Knowledge discovery in traditional Chinese medicine: State of the art and perspectives
    Feng, Yi
    Wu, Zhaohui
    Zhou, Xuezhong
    Zhou, Zhongmei
    Fan, Weiyu
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2006, 38 (03) : 219 - 236
  • [2] Traditional Chinese herbal injection: Current status and future perspectives
    Li, Haona
    Wang, Siwang
    Yue, Zhihua
    Ren, Xuequn
    Xia, Jielai
    FITOTERAPIA, 2018, 129 : 249 - 256
  • [3] Opportunities and hurdles to European market access for multi-herbal traditional Chinese medicine products: An analysis of EU regulations for combination herbal medicinal products
    Qu, Liping
    Li, Xiuli
    Xiong, Yin
    Wang, Zhun
    Zhou, Yuehua
    Zou, Wenjun
    Tang, Jianyuan
    Wang, Mei
    PHARMACOLOGICAL RESEARCH, 2022, 186
  • [4] Nano Traditional Chinese Medicine: Current Progresses and Future Challenges
    Huang, Yi
    Zhao, Yinglan
    Liu, Fang
    Liu, Songqing
    CURRENT DRUG TARGETS, 2015, 16 (13) : 1548 - 1562
  • [5] Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach
    Zhang, Aihua
    Sun, Hui
    Wang, Ping
    Han, Ying
    Wang, Xijun
    COMPLEMENTARY THERAPIES IN MEDICINE, 2012, 20 (1-2) : 93 - 99
  • [6] Traditional Chinese Medicine and renal regeneration: experimental evidence and future perspectives
    Zhang, Denglu
    Jiang, Huihui
    Yang, Xianzhen
    Zheng, Sanxia
    Li, Yi
    Liu, Shuai
    Xu, Xiangdong
    CHINESE MEDICINE, 2024, 19 (01):
  • [7] Incomplete Immune Reconstitution and Traditional Chinese Medicine in Patients with HIV/ AIDS: Challenges and Perspectives
    Ding, Xue
    Fan, Leilei
    Xu, Liran
    Ma, Xiuxia
    Meng, Pengfei
    Li, Jie
    Li, Jiahe
    Yue, Jingyu
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 5827 - 5838
  • [8] THE FUTURE AND PROSPECTS OF THE TRADITIONAL CHINESE MEDICINE ON THE EU MARKET UNDER NEW REGULATORY FRAMEWORK
    Virtosu, Ina
    MEDICINE AND LAW, 2018, 37 (01): : 245 - 275
  • [9] Exploiting the nanotechnological approaches for traditional Chinese medicine in childhood rhinitis: A review of future perspectives
    Zhang, Yao
    Dong, Haicheng
    Zhu, Yu
    Wang, Wenfei
    Zhang, Xinyue
    NANOTECHNOLOGY REVIEWS, 2024, 13 (01)
  • [10] Spectrum-Effect Relationships as a Systematic Approach to Traditional Chinese Medicine Research: Current Status and Future Perspectives
    Xu, Guan-Ling
    Xie, Meng
    Yang, Xiao-Yan
    Song, Yan
    Yan, Cheng
    Yang, Yue
    Zhang, Xia
    Liu, Zi-Zhen
    Tian, Yu-Xin
    Wang, Yan
    Jiang, Rui
    Liu, Wei-Rui
    Wang, Xiao-Hong
    She, Gai-Mei
    MOLECULES, 2014, 19 (11) : 17897 - 17925